1.Padhani,
A R.
2014.
“Lymph Nodes.” In Recommendations for Cross-Sectional Imaging in Cancer Management,
edited by T Nicholson,
Second edi.
London: The Royal College of Radiologists.
2.McMahon,
Colm J,
Neil M Rofsky,
and Ivan Pedrosa.
2010.
“Lymphatic Metastases from Pelvic Tumors : Anatomic.” Radiology 254 (1–46).
3.Torabi,
Maha,
Suzanne L.
Aquino,
and Mukesh G.
Harisinghani.
2004.
“Current Concepts in Lymph Node Imaging.” J.
Nucl.
Med. 45 (9): 1509–18.
4.Kim,
Sungheon Gene,
Kent Friedman,
Sohil Patel,
and Mari Hagiwara.
2016.
“Potential Role of PET/MRI for Imaging Metastatic Lymph Nodes in Head and Neck Cancer.” American Journal of Roentgenology 207 (2): 248–56.
5.Wang,
Haiyan,
Qing Kay Li,
Martin Auster,
and Gary Gong.
2018.
“PET and CT Features Differentiating Infectious/Inflammatory from Malignant Mediastinal Lymphadenopathy: A Correlated Study with Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration.” Radiology of Infectious Diseases 5 (1).
Elsevier Ltd: 7–13.
6.American Joint Comitee on cancer.what is cancer staging?http://cancerstaging.org/referncestools/Pages/What-is-Cancer-Staging.aspx.
Accessed on 07.01.2019
7.Gress,
Donna M,
Stephen B Edge,
Frederick L.
Greene,
Mary Kay Washington,
Elliot A.
Asare,
James D.
Brierley,
David R.
Byrd,
et al.
2010.
Principles of Cancer Staging.
AJCC Cancer Staging Manual.
Eigth Edit.
8.Takada,
Juichi,
Hisashi Hidaka,
Takahide Nakazawa,
Masaaki Kondo,
Kazushi Numata,
Katsuaki Tanaka,
Kotaro Matsunaga,
et al.
2015.
“Modified Response Evaluation Criteria in Solid Tumors Is Superior to Response Evaluation Criteria in Solid Tumors for Assessment of Responses to Sorafenib in Patients with Advanced Hepatocellular Carcinoma Cancer.” BMC Research Notes 8 (1).
BioMed Central: 1–10.
9.Bell,
Daniel J,
Usman Bashir,
and Et Al.
2018.
“RECIST 1.1: Comparison with RECIST 1.0.” 2018.
https://radiopaedia.org/articles/recist-11-comparison-with-recist-10-2/revisions?lang=us.Accessed on 08.01.2019
10.Eisenhauer,
E.
A.,
P.
Therasse,
J.
Bogaerts,
L.
H.
Schwartz,
D.
Sargent,
R.
Ford,
J.
Dancey,
et al.
2009.
“New Response Evaluation Criteria in Solid Tumours: Revised RECIST Guideline (Version 1.1).” European Journal of Cancer 45 (2).
Elsevier Ltd: 228–47.
11.Cheson,
Bruce D.,
Beate Pfistner,
Malik E.
Juweid,
Randy D.
Gascoyne,
Lena Specht,
Sandra J.
Horning,
Bertrand Coiffier,
et al.
2007.
“Revised Response Criteria for Malignant Lymphoma.” Journal of Clinical Oncology 25 (5): 579–86.
12.Fournier,
L.,
S.
Ammari,
R.
Thiam,
and C.
A.
Cuénod.
2014.
“Imaging Criteria for Assessing Tumour Response: RECIST,
MRECIST,
Cheson.” Diagnostic and Interventional Imaging 95 (7–8).
Elsevier Masson SAS: 689–703.
https://doi.org/10.1016/j.diii.2014.05.002.
13.Johnson,
Sarah A,
Anita Kumar,
and Matthew J Matasar.
2015.
“Imaging for Staging and Response Assessment in Lymphoma” 276 (2).
14.Morón,
F E,
and J Szklaruk.
2007.
“Learning the Nodal Stations in the Abdomen.” The British Journal of Radiology 80 (958): 841–48.
15.Head and Neck Cancer Guide.“Metastatic Lymph Nodes.” Accessed January 8,
2019.
https://headandneckcancerguide.org/adults/introduction-to-head-and-neck-cancer/neck-cancer/metastatic-lymph-nodes/anatomy/%0D.